| Literature DB >> 33195380 |
Sachin Arakere Nataraj1, Feroz Amir Zafar1, Prasun Ghosh1, Rajesh Ahlawat1.
Abstract
Introduction: The aim of the study was to report the perioperative and functional results of Robotic assisted kidney transplantation (RAKT) in Grafts with multiple vessels (GMVs) and compare it to the results of Open kidney transplantation (OKT) with GMVs. Materials andEntities:
Keywords: Vattikuti-Medanta technique; grafts with multiple vessels; open kidney transplantation; robotic assisted kidney transplantation; robotic surgery
Year: 2020 PMID: 33195380 PMCID: PMC7477351 DOI: 10.3389/fsurg.2020.00051
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Surgical technique for extracorporeal (ex vivo) or in situ reconstruction for open and robot-assisted kidney transplantation.
| Conjoined (side-to-side) arterial anastomosis ( | 17 | 25 |
| Polar artery anastomosis to the inferior epigastric artery | 8 | 7 |
| Separate arterial anastomoses (end-to-side) to external iliac artery | 1 | 1 |
| Separate arterial anastomoses (end-to-end) to internal iliac artery and (end-to-side) external iliac artery | 3 | 0 |
| Arterial anastomoses to branches of hypogastric artery | 0 | 0 |
| Ligation of small accessory artery, especially if supplying the upper renal pole | 3 | 3 |
| Pantaloon + Anastomoses to inferior epigastric artery | 6 | 5 |
| Separate venous anastomoses (end-to-side) to external iliac vein | 4 | 2 |
| None (Ligation of small renal vein) | 1 | 1 |
Figure 1Intraciperative images showing ex-vivo bench vascular reconstruction of 3 separate renal arteries, 2 of approximately same calibre from a live related donor. (A) Preparation of pantaloon from arteries of same calibre. (B) After completion of Pantaloon.
Figure 2Arterial anastomosis between the reconstructed graft renal artery (side-to-side arterial anastomosis in a pantaloon fashion between the two renal arteries) and the external iliac artery.
Figure 3Intraoperative snapshots during robot-assisted kidney transplantation in case of grafts with multiple vessels. (A) Preparation of inferior epigastric artery. (B,C) Anasturrrosis between inferior epigastric artery and accessory lower pole renal artery.
Figure 4CT angiogram after 3 months after RAKT showing patent Pantaloon and accessory lower pole vessel anastomosis.
Propensity score matching (PSM) of the two groups.
| Age (y), mean ± SD | 43.5 ± 12.8 | 41.2 ± 12.6 | 0.7 | 0.02 | 42 ± 15 | 40.3 ± 13.4 | 0.8 | 0.01 |
| Male sex, | 77 (75) | 35 (70) | 0.1 | −0.01 | 27 (65) | 30 (70) | 0.2 | 0.04 |
| BMI, kg/m2 | ||||||||
| mean ± SD | 21.3 ± 4 | 27.3 ± 3.9 | 0.04 | 0.07 | 22.6 ± 4.4 | 26.8 ± 4.2 | 0.05 | 0.02 |
| Charlson comorbidity index, | ||||||||
| 2 | 65 (63) | 35 (70) | 27 (63) | 29 (67) | ||||
| 3 | 21 (20) | 11 (22) | 0.03 | −0.17 | 09 (21) | 10 (24) | 0.4 | 0.25 |
| 4 | 17 (17) | 04 (08) | 07 (16) | 04 (9) | ||||
| Diabetes Mellitus | 19 | 12 | 0.4 | 0.1 | 6 (14) | 7 (14.5) | 0.9 | −0.01 |
| Preoperative eGFR (ml/min/1.73 m2) | ||||||||
| mean ± SD | 10 ± 5.3 | 10.4 ± 4.8 | 0.6 | 0.02 | 11 ± 3.9 | 10.8 ± 4.3 | 0.8 | 0.01 |
| Median (IQR) | 9.8 (7.8-13.9) | 11 (8.2–14.2) | 10 (8–12.9) | 11.3 (8.6–14.5) | ||||
| Pre-emptive, | 16 (15) | 12 (24) | 0.5 | 0.15 | 9 (21) | 10 (23.2) | 0.3 | 0.07 |
| Vascular anatomy | 2:1 (77[75]) | 2:1 (41 [82]) | 2:1 (34[80]) | 2:1 (35 [82]) | 0.5 | 0.02 | ||
| Arteries: Veins | 3:1 (21 [20]) | 3:1 (6 [11]) | 3:1 (7 [15]) | 3:1 (5 [11]) | ||||
| ( | 1:2 (5[5]) | 1:2 (3 [7]) | 0.7 | 0.2 | 1:2 (2 [5]) | 1:2 (3 [7]) | ||
| Duration of Dialysis | 316 (18–455) | 308 (20–500) | 290 (22–360) | 300 (20–470) | 0.9 | 0.04 | ||
| Side of transplant | ||||||||
| Left | 2 | 050 | 0.4 | 0.01 | 0 43 | 043 | 0.9 | 0.2 |
| Donor Characteristics | ||||||||
| Age (y), mean ± SD | 47 ± 12 | 49 ± 12 | 0.5 | 0.04 | 45.8 ± 11.7 | 46.3 ± 12.8 | 0.4 | 0.9 |
Data are presented as frequencies and percentages (%) or mean ± SD.
Standardized difference = difference in mean or proportions divided by the standard error; imbalance between groups was defined as absolute value >0.10 (corresponding to a small effect size).
Intraoperative outcomes.
| Operative time (min) Median | 235 (190–300) | 250 (210–300) | 0.6 |
| Console time (min) | Not Applicable | 170 (130–200) | |
| Warm ischemia time (min) | 2.5 (2–4) | 3 (2–5) | 0.09 |
| Cold ischemia time (min) | 29 (18–35) | 33 (25–40) | 0.08 |
| Rewarming time (min) | 56 (48–71) | 60 (50–75) | 0.2 |
| Total Ischemia time (min) | 86 (65–98) | 90 (70–105) | 0.1 |
| Estimated blood loss (ml) | 200 (90–300) | 160 (70–180) | 0.5 |
| Surgical incision length (cms) | 16 (15–18) | 5.5 (5–7) | 0.04 |
| Conversion | NA | 0 |
Overall times for anastomosis during RAKT and OKT (min) (median, IQR).
| Arterial | 12 (9–18) | 13 (8–18) | 0.7 |
| Venous | 11 (6–15) | 7 (7–17) | 0.6 |
| Accessory artery | 18 (12–28) | 18 (13–30) | 0.8 |
| Uretero-vesical | 18 (12–32) | 19 (14–32) | 0.7 |
Figure 7Box plot showing time for arterial anastomosis.
Figure 10Box plot time for uretero-vesical anastomosis.
Postoperative outcomes.
| Postoperative pain (VAS scale) | |||
| 12 h | 6 | 5 | 0.8 |
| 24 h | 5 | 3 | 0.04 |
| 48 h | 4 | 2 | 0.03 |
| Mean Analgesic requirement in grams on POD 1 | 4 ± 0.3 | 2 ± 0.15 | 0.02 |
| Drain removal (median, range) | 3 (2–5) | 6 (4–11) | 0.004 |
| Double J stent removal (median, range) | 21 (13–100) | 17 (12–50) | 0.09 |
| Hospital stay | 10 (7–21) | 7 (5–15) | 0.05 |
| Re-admission rate | 10 | 8 | 0.8 |
| Acute rejection | 3 | 2 | 0.3 |
| UTI | 3 | 3 | 0.5 |
| Fever | 4 | 3 | 0.8 |
Modified Clavien–Dindo Grading System of complications.
| I | |||
| Bleeding | 2 | 3 | 0.8 |
| Wound infection | 0 | 6 | 0.04 |
| Ileus | 8 | 1 | 0.03 |
| II | |||
| Haemorrhages requiring transfusions | 3 | 6 | 0.126 |
| IIIa | NA | ||
| Lymphoceles | 0 | 0 | |
| IIIb | |||
| Graft vessel thrombosis | 0 | 0 | |
| Re–exploration | 0 | 0 | NA |
| Graft Nephrectomy | 0 | 0 | |
| IVa | |||
| Delayed graft function requiring temporary dialysis | 0 | 0 | NA |
| Biopsy proven rejection of Rejection of graft | 2 | 3 | 0.8 |
| IVb | 0 | 0 | NA |
| V | 0 | 0 | NA |
Functional outcomes.
| Median eGFR (ml/min/1.73 m2) | |||
| POD 1 | 22.8 (13–25.7) | 21.5 (16.0–28.4) | 0.9 |
| POD2 | 41.7 (25.0–58.0) | 42.2 (30.8–53.6) | 0.6 |
| POD3 | 58.0 (44.0–74.0) | 57.1 (41.8–66.5) | 0.5 |
| Serum Creatinine | |||
| Mean (SD) | |||
| At Discharge | 1.46 (1.12) | 1.6 (1.32) | 0.6 |
| At 1 month | 1.39 (1.30) | 1.5 (1.40) | 0.5 |
| At 3 months | 1.14 (1.03) | 1.25 (1.42) | 0.2 |
| At 6 months | 1.07 (0.90) | 1.12 (1.03) | 0.4 |
| Mean e GFR at 6 months (death censored) ml/ min/1.73 m2 | 61.8 ± 16 | 62.4 ± 24 | 0.9 |
| Delayed Graft function, | 0 | 0 |
Figure 5Kaplan-Meier curve of kidney allograft survival (censored for recipient death).
Figure 6Overall survival.